Trial Profile
Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH) DeWorm3 Project
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 Feb 2024
Price :
$35
*
At a glance
- Drugs Albendazole (Primary)
- Indications Helminthiasis
- Focus Therapeutic Use
- 05 Feb 2024 Planned End Date changed from 1 Apr 2024 to 1 May 2024.
- 05 Feb 2024 Planned primary completion date changed from 1 Apr 2024 to 1 May 2024.
- 05 Feb 2024 Status changed from completed to active, no longer recruiting.